Skip to content
Benefits & EvidenceEvidence-Tiered

AOD-9604 Benefits

What does AOD-9604 actually do? We break down the evidence by tier — human data, animal studies, and in vitro research — with citations for every claim.

Quick Answer

AOD-9604 has been researched for its potential to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat formation), primarily through the beta-3 adrenergic pathway. Unlike full hGH, it doesn't raise IGF-1 levels or affect blood glucose. Early studies also hint at chondrocyte stimulation.

→ AOD-9604 Dosage→ AOD-9604 Side Effects→ Full AOD-9604 Profile

Evidence Tiers

HumanClinical or observational human dataAnimalPreclinical in vivo studiesIn VitroCell / tissue culture studies
Table of Contents

Mechanism of Action

AOD-9604 acts by mimicking the lipolytic region of human growth hormone, interacting with the beta-3 adrenergic receptors on fat cells. This interaction stimulates fat breakdown and reduces fat storage. Notably, it doesn't bind to the actual growth hormone receptor, which minimizes effects on IGF-1 levels and avoids potential growth-promoting risks. Some research also indicates interaction with chondrocytes, suggesting cartilage repair potential.

Human Evidence

Human1 finding

Modest fat loss (clinical trials)

Phase 2 clinical trials showed modest, but not always statistically significant, fat loss in overweight/obese individuals. Results were somewhat inconsistent across trials.

PubMed 12897174 (2003) ↗

Animal Studies

Animal1 finding

Reduced body fat in obese rats

Studies in obese Zucker rats demonstrated that AOD-9604 reduced body fat mass, particularly in abdominal regions. These effects were attributed to increased lipolysis.

PubMed 11713213 (2001) ↗

In Vitro Research

In Vitro1 finding
In vitro (cell culture) findings are the earliest stage of evidence. They indicate mechanism plausibility but cannot confirm human effects.

Chondrocyte proliferation and differentiation

In vitro studies showed that AOD-9604 stimulated the proliferation and differentiation of chondrocytes (cartilage cells), suggesting potential cartilage repair properties.

PubMed 16003761 (2005) ↗

What's Proven vs What's Still Unknown

✓ What the Evidence Supports

  • ✓Stimulates lipolysis in vitro
  • ✓Reduces body fat in obese rat models
  • ✓Does not significantly elevate IGF-1 levels
  • ✓Shows affinity for chondrocyte receptors

? Still Unknown or Unconfirmed

  • ?Long-term efficacy and safety in humans
  • ?Optimal dosage and administration route for cartilage repair
  • ?Effectiveness in combination with other therapies
  • ?Clinical significance of chondrocyte stimulation

Frequently Asked Questions

How does AOD-9604 compare to full-length hGH for fat loss?
AOD-9604 is a fragment of hGH designed to stimulate fat loss without the growth-promoting and diabetogenic effects of full hGH. It does not elevate IGF-1 or affect blood glucose, making it potentially safer but also likely less potent for fat loss than hGH itself.
Is AOD-9604 effective for cartilage repair?
In vitro studies show that AOD-9604 stimulates chondrocyte proliferation, suggesting potential cartilage repair properties. However, there is very limited human clinical data on this application, and it is not FDA-approved for cartilage repair.
What are the main benefits of AOD-9604?
The main researched benefits include stimulation of fat breakdown without the side effects of hGH, potential cartilage repair properties, and a generally favorable safety profile in clinical trials. More research is needed to confirm these benefits definitively.
Does AOD-9604 affect appetite?
Unlike some weight-loss drugs that work by suppressing appetite, AOD-9604 is believed to target fat metabolism directly without affecting CNS appetite pathways. Clinical trials have not reported significant effects on appetite.

References

  1. 1
    A synthetic fragment of human growth hormone (AOD9604) that reduces body fat in obese Zucker rats(2001)PubMed ↗
  2. 2
    AOD9604, a novel lipolytic peptide fragment of human growth hormone: safety, tolerability, and pharmacokinetics in healthy subjects(2003)PubMed ↗
  3. 3
    The effect of the C-terminal fragment of human growth hormone on the proliferation and differentiation of chondrocytes(2005)PubMed ↗

Last updated: 2026-02-19